Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Join Canadian Insider Club or Club Ultra to Keep Your Edge

Times are changing, ad revenues are plunging, and Canadian data costs have jumped.

Starting this summer, we will be limiting Canadian company page views to 10 per month for non-members.

Canadian Insider Club members will continue to get Google ad-free and unlimited access to canadianinsider.com.

Join the club to keep your edge! For a limited time, use coupon code SAVE99 to save $99* off a Canadian Insider Club Membership.

*Save $99 on the first year of a new Canadian Insider Club or Canadian Insider Club Ultra membership. Subsequent auto-renewals will be at the standard rate unless canceled. Limited time offer.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

Aug 10, 2020 08:50 am ET
Khiron Signs First Kuida™ Distribution Deal in Hong Kong
Breakthrough Agreement Brings CBD Skincare Brand to World Leading Asia Pacific Market
Jul 27, 2020 06:55 am ET
Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone
Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization for the sale of magistral preparation of high-THC medical cannabis in Colombia, and as a result Khiron is the first and only company to manufacture and sell high-THC medic
Jul 27, 2020 06:55 am ET
Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone
Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization for the sale of magistral preparation of high-THC medical cannabis in Colombia, and as a result Khiron is the first and only company to manufacture and sell high-THC medic...
Jul 23, 2020 06:55 am ET
Khiron to Commercialize Medical Cannabis in Peru
Khiron has received all necessary licenses and authorizations allowing full spectrum, high-CBD medical cannabis products to be exported from Colombia for import and commercialization in Peru Full spectrum high CBD medical cannabis will be supplied by Khiron Colombia and manufactured and distributed to patients under the previously announced agreement with Farmacia Universal First patient prescriptions anticipated to be filled in Q3 2020 Receipt of import license and corresponding Colombian authorizations complete all requirements for entry into the Peruvian high CBD medical cannabis market E...
Jul 23, 2020 06:55 am ET
Khiron to Commercialize Medical Cannabis in Peru
Khiron has received all necessary licenses and authorizations allowing full spectrum, high-CBD medical cannabis products to be exported from Colombia for import and commercialization in Peru Full spectrum high CBD medical cannabis will be supplied by Khiron Colombia and manufactured and distributed to patients under the previously announced agreement with Farmacia Universal First patient prescriptions anticipated to be filled in Q3 2020 Receipt of import license and corresponding Colombian authorizations complete all requirements for entry into the Peruvian high CBD medical cannabis market E
Jul 21, 2020 04:02 pm ET
Khiron Announces Change of Auditor
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), announces that MNP LLP (the “Former Auditor”) have, at the request of the Company, resigned as auditors of the Company, effective July 10,...
Jul 17, 2020 06:55 am ET
Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour
Attendees are invited to attend a real-time, interactive tour of Khiron's recently completed Zerenia medical facility
Jul 17, 2020 06:55 am ET
Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour
Attendees are invited to attend a real-time, interactive tour of Khiron's recently completed Zerenia medical facility...
Jul 02, 2020 07:00 am ET
Khiron Expands EU Footprint, Signing Kuida™ Distribution Deal in Spain
Kuida CBD skincare products to be distributed through 2,350 stores across four drug store health and beauty distributor groups in Spain Deal with Red Yellow Red, a leading cosmetic products master distributor, representing access to a combined 20,000 stores in Spain and Portugal Kuida product training, CBD category education, and brand promotional activity to support drug store distribution Spain represented a total skincare market of €1.5 billion in 2018 and is expected to reach €1.8 billion by 2023 (Source: Euromonitor - Passport) TORONTO, July 2, 2020 /CNW/ - Khiron Life Sciences Corp. (
Jul 02, 2020 07:00 am ET
Khiron Expands EU Footprint, Signing Kuida™ Distribution Deal in Spain
Kuida CBD skincare products to be distributed through 2,350 stores across four drug store health and beauty distributor groups in Spain Deal with Red Yellow Red, a leading cosmetic products master distributor, representing access to a combined 20,000 stores in Spain and Portugal Kuida product training, CBD category education, and brand promotional activity to support drug store distribution Spain represented a total skincare market of €1.5 billion in 2018 and is expected to reach €1.8 billion by 2023 (Source: Euromonitor - Passport) TORONTO, July 2, 2020 /PRNewswire/ - Khiron Life Sciences ...
Jun 26, 2020 08:35 am ET
Cannabis Industry Company Investor Presentations Now Available for On-Demand Viewing
NEW YORK, June 26, 2020 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 24th cannabis conference are now available for on-demand viewing at VirtualInvestorConferences.com. ...
Jun 25, 2020 10:05 am ET
Khiron Signs Distribution Deal in Germany for Medical Cannabis Imports and Sales
Khiron partners with Nimbus Health, a leading medical cannabis distributor in Germany, with broad reach into domestic pharmacies First import and sales of Khiron branded EU GMP medical cannabis products are expected in Q3/20 Medical education and marketing activities to begin imminently Germany is the largest medical cannabis market in Europe with €123M of fully reimbursed patient prescriptions in 2019 (source: GKV) By 2028, the German medical cannabis market is predicted to be worth nearly €7.7bn (source: Prohibition Partners) TORONTO, June 25, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khi
Jun 25, 2020 10:05 am ET
Khiron Signs Distribution Deal in Germany for Medical Cannabis Imports and Sales
Khiron partners with Nimbus Health, a leading medical cannabis distributor in Germany, with broad reach into domestic pharmacies First import and sales of Khiron branded EU GMP medical cannabis products are expected in Q3/20 Medical education and marketing activities to begin imminently Germany is the largest medical cannabis market in Europe with €123M of fully reimbursed patient prescriptions in 2019 (source: GKV) By 2028, the German medical cannabis market is predicted to be worth nearly €7.7bn (source: Prohibition Partners) TORONTO, June 25, 2020 /PRNewswire/ - Khiron Life Sciences Corp...
Jun 24, 2020 07:00 am ET
/C O R R E C T I O N from Source -- Khiron Life Sciences Corp./
In the news release, Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia, issued 24-Jun-2020 by Khiron Life Sciences Corp. over CNW, we are advised by the company that the second bullet point in the subheadline should read "570 tons" rather than "7 tons" as originally issued inadvertently. The complete, corrected release follows:...
Jun 24, 2020 07:00 am ET
Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia
Solar park can generate up to 40% of the energy needs at its 5 hectare facility in Doima, Colombia Project demonstrates Khiron's commitment to sustainability by reducing its carbon footprint by approximately 7 tons of CO2 a year, while decreasing operational energy costs TORONTO, June 24, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces the completed installation of a state-of-the-art 2,600 panel solar park that will gener
Jun 22, 2020 02:51 pm ET
Khiron CEO and Board Chair to Participate in Live Webcast on June 24th
TORONTO, June 22, 2020 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and director, and Chris Naprawa, Khiron Board Chair and director will present live at VirtualInvestorConferences.com on June 24th. ...
Jun 22, 2020 08:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present June 24th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Jun 22, 2020 08:30 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present June 24th
NEW YORK, June 22, 2020 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 10:15 AM ET, with the first live webcast at 10:30 AM ET, on Wednesday, June 24th.   ...
Jun 22, 2020 07:00 am ET
Khiron CEO and Board Chair to Participate in Live Webcast on June 24th
Individual and institutional investors, as well as advisors and analysts are invited to attend a real-time, interactive presentation on VirtualInvestorConferences.com...
Jun 22, 2020 07:00 am ET
Khiron CEO and Board Chair to Participate in Live Webcast on June 24th
Individual and institutional investors, as well as advisors and analysts are invited to attend a real-time, interactive presentation on VirtualInvestorConferences.com
Jun 12, 2020 04:00 pm ET
Khiron Appoints Chris Naprawa to Director, and Chairman of the Board
TORONTO, June 12, 2020 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces today the appointment of Chris Naprawa as Director and  Chairman of the Board. In transitioning from his current role as President, Chris will continue to guide the Company and Board as Khiron continues its commercialization phase of its medical cannabis business strategy in Latin America and globally. The Company further announces that Michael Beck ha...
Jun 12, 2020 04:00 pm ET
Khiron Appoints Chris Naprawa to Director, and Chairman of the Board
TORONTO, June 12, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces today the appointment of Chris Naprawa as Director and  Chairman of the Board. In transitioning from his current role as President, Chris will continue to guide the Company and Board as Khiron continues its commercialization phase of its medical cannabis business strategy in Latin America and globally. The Company further announces that Michael Beck has resig
May 28, 2020 04:05 pm ET
Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results
Closed quarter with net working capital of $28.4 million Achieved revenues of $1.9 Million for Q1 2020, improving gross margin by 17% compared to Q1 2019 Achieved first sales in Colombia of low-THC medical cannabis, and subsequent to the quarter, began its first high-THC medical cannabis sales in Colombia on May 19th 2020 Increased revenues from its Kuida® brand by 18% compared to Q1 2019, despite the impact of sales reduction in March due to the COVID-19 pandemic in Colombia and abroad In May 2020, received first medical cannabis prescriptions for UK patients participating in Project Twenty...
May 28, 2020 04:05 pm ET
Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results
Closed quarter with net working capital of $28.4 million Achieved revenues of $1.9 Million for Q1 2020, improving gross margin by 17% compared to Q1 2019 Achieved first sales in Colombia of low-THC medical cannabis, and subsequent to the quarter, began its first high-THC medical cannabis sales in Colombia on May 19th 2020 Increased revenues from its Kuida® brand by 18% compared to Q1 2019, despite the impact of sales reduction in March due to the COVID-19 pandemic in Colombia and abroad In May 2020, received first medical cannabis prescriptions for UK patients participating in Project Twenty
May 20, 2020 12:05 am ET
Khiron Begins Sales of First High-THC Medical Cannabis in Colombia
Khiron is the first company to receive authorization to commercialize high-THC medical cannabis magistral preparations from Colombia's National Narcotics Fund Authorization is supplementary to the previously announced high-THC extraction and cultivation quotas from the Colombian Technical Quotas Group Effective immediately, prescriptions will be filled through Company's ILANS clinics, with expanded distribution in Colombia as partner pharmacies receive dispensary permits Company's ILANS clinics are fully authorized to dispense Khiron's high-THC products for various indications including chro
May 20, 2020 12:05 am ET
Khiron Begins Sales of First High-THC Medical Cannabis in Colombia
Khiron is the first company to receive authorization to commercialize high-THC medical cannabis magistral preparations from Colombia's National Narcotics Fund Authorization is supplementary to the previously announced high-THC extraction and cultivation quotas from the Colombian Technical Quotas Group Effective immediately, prescriptions will be filled through Company's ILANS clinics, with expanded distribution in Colombia as partner pharmacies receive dispensary permits Company's ILANS clinics are fully authorized to dispense Khiron's high-THC products for various indications including chro...
May 07, 2020 04:05 pm ET
Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference
TORONTO, May 7, 2020 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that President Chris Naprawa will present live at Canaccord Genuity's 4th Annual Global Cannabis Virtual Conference on Tuesday, May 12, 2020 at 11:40am ET (8:40am PT)....
May 07, 2020 04:05 pm ET
Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference
TORONTO, May 7, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that President Chris Naprawa will present live at Canaccord Genuity's 4th Annual Global Cannabis Virtual Conference on Tuesday, May 12, 2020 at 11:40am ET (8:40am PT).
May 06, 2020 12:01 am ET
Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21
Khiron is the exclusive Latin American supplier to Project Twenty21, a leading UK registry study enrolling up to 20,000 patients by the end of 2021, to create the largest body of evidence in Europe for the effectiveness and tolerability of medical cannabis...
May 06, 2020 12:01 am ET
Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21
Khiron is the exclusive Latin American supplier to Project Twenty21, a leading UK registry study enrolling up to 20,000 patients by the end of 2021, to create the largest body of evidence in Europe for the effectiveness and tolerability of medical cannabis
May 01, 2020 06:05 pm ET
Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update
Net working capital of $36.4 Million CAD at December 31, 2019 On March 20, 2020 Khiron became the first and only company in Colombia to receive full authorization to manufacture high- and low-THC medical cannabis, and to fill prescriptions for low-THC medical cannabis Khiron became the only Company authorized to export THC products Filled first medical cannabis prescriptions ever using cannabis from their fully completed state-of-the-art, 14,000 square foot GMP and ISO 17025 compliant extraction and analysis lab in Ibague, Colombia Opened European operations, and became the exclusive Latin A
May 01, 2020 06:05 pm ET
Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update
Net working capital of $36.4 Million CAD at December 31, 2019 On March 20, 2020 Khiron became the first and only company in Colombia to receive full authorization to manufacture high- and low-THC medical cannabis, and to fill prescriptions for low-THC medical cannabis Khiron became the only Company authorized to export THC products Filled first medical cannabis prescriptions ever using cannabis from their fully completed state-of-the-art, 14,000 square foot GMP and ISO 17025 compliant extraction and analysis lab in Ibague, Colombia Opened European operations, and became the exclusive Latin A...
Apr 30, 2020 04:01 pm ET
Khiron Signs Exclusive Agreement with Medlive, a Distributor Serving 3,000 Clinics and Hospitals in Brazil
Exclusive agreement with Medlive, a pharmaceutical and health products distributor with network of over 3,000 clinics and hospitals in southern Brazil Company's medical cannabis products will be marketed through Medlive network of doctor offices, clinics, hospitals and governmental institutions Medical education, marketing activities and sales are planned to start in Q3 2020 Brazil represents the largest addressable market in Latin America with a population of approximately 212 million TORONTO, April 30, 2020 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)...
Apr 30, 2020 04:01 pm ET
Khiron Signs Exclusive Agreement with Medlive, a Distributor Serving 3,000 Clinics and Hospitals in Brazil
Exclusive agreement with Medlive, a pharmaceutical and health products distributor with network of over 3,000 clinics and hospitals in southern Brazil Company's medical cannabis products will be marketed through Medlive network of doctor offices, clinics, hospitals and governmental institutions Medical education, marketing activities and sales are planned to start in Q3 2020 Brazil represents the largest addressable market in Latin America with a population of approximately 212 million TORONTO, April 30, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQ
Apr 28, 2020 07:00 am ET
Khiron Provides Update on Filing of its 2019 Year End Results
Company filing date moved from April 29 to estimate of May 1 to allow auditors to complete audit delayed as a result of COVID-19 situation  Filing extension provided by Ontario Securities Commission on March 23, 2020 in response to COVID-19 pandemic TORONTO, April 28, 2020 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that it will delay the filing of its audited financial statements and accompanying management's discussion and a...
Apr 28, 2020 07:00 am ET
Khiron Provides Update on Filing of its 2019 Year End Results
Company filing date moved from April 29 to estimate of May 1 to allow auditors to complete audit delayed as a result of COVID-19 situation  Filing extension provided by Ontario Securities Commission on March 23, 2020 in response to COVID-19 pandemic TORONTO, April 28, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that it will delay the filing of its audited financial statements and accompanying management's discussion and analysis
Apr 22, 2020 12:01 am ET
Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel
Khiron's medical cannabis products to be carried at Locatel's large-format pharmacy locations in Colombia Locatel is an important pharmacy, healthcare products and medical equipment retailer in Colombia with a database of 2 million patients and customers, and experience managing magistral preparations Locatel e-commerce channels enable product deliveries to all markets and territories across Colombia Locatel's operations deemed an essential service in Colombia during COVID-19 pandemic, ensuring continued access to filling and delivery of prescriptions TORONTO, April 22, 2020 /CNW/ - Khiron
Apr 22, 2020 12:01 am ET
Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel
Khiron's medical cannabis products to be carried at Locatel's large-format pharmacy locations in Colombia Locatel is an important pharmacy, healthcare products and medical equipment retailer in Colombia with a database of 2 million patients and customers, and experience managing magistral preparations Locatel e-commerce channels enable product deliveries to all markets and territories across Colombia Locatel's operations deemed an essential service in Colombia during COVID-19 pandemic, ensuring continued access to filling and delivery of prescriptions TORONTO, April 22, 2020 /PRNewswire/ - ...
Apr 03, 2020 07:50 am ET
Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update
Khiron to report Q4 and Year End Results on April 28, and webcast Q&A will be held the following day Khiron finished the 2019 calendar year with approximately $36 Million CAD in cash and working capital Khiron and its clinics operational during COVID-19 pandemic under an exemption decreed by the Government of Colombia, without any requirement for further authorization Active teleconsultation services complement Khiron's delivery service that is already delivering medical cannabis prescriptions directly to patients' homes Online education program bringing medical cannabis education to 1,5...
Apr 03, 2020 07:50 am ET
Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update
Khiron to report Q4 and Year End Results on April 28, and webcast Q&A will be held the following day Khiron finished the 2019 calendar year with approximately $36 Million CAD in cash and working capital Khiron and its clinics operational during COVID-19 pandemic under an exemption decreed by the Government of Colombia, without any requirement for further authorization Active teleconsultation services complement Khiron's delivery service that is already delivering medical cannabis prescriptions directly to patients' homes Online education program bringing medical cannabis education to 1,5
Mar 31, 2020 06:56 pm ET
Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University
Agreement with Tecnologico de Monterrey, a leading Latin American university (Third Ranked in Latin America) in Mexico brings Khiron´s online education program to reach 1,500 physicians, healthcare practitioners and beyond...
Mar 31, 2020 06:56 pm ET
Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University
Agreement with Tecnologico de Monterrey, a leading Latin American university (Third Ranked in Latin America) in Mexico brings Khiron´s online education program to reach 1,500 physicians, healthcare practitioners and beyond
Mar 30, 2020 08:21 pm ET
Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia
Starting April 1st, Company's virtual consultation service gives patients access to clinic services and doctors trained to prescribe medical cannabis Teleconsultation service anticipated to quickly expand to meet potential growing demand for telehealth services, including Company's 120,000 patients from its ILANS and Zerenia clinics Khrion has already received initial approvals from third party payers to include teleconsultation services in its insured service offerings Khiron and its clinics continue to be operational during COVID-19 pandemic under an exemption decreed by the Government of
Mar 30, 2020 08:21 pm ET
Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia
Starting April 1st, Company's virtual consultation service gives patients access to clinic services and doctors trained to prescribe medical cannabis Teleconsultation service anticipated to quickly expand to meet potential growing demand for telehealth services, including Company's 120,000 patients from its ILANS and Zerenia clinics Khrion has already received initial approvals from third party payers to include teleconsultation services in its insured service offerings Khiron and its clinics continue to be operational during COVID-19 pandemic under an exemption decreed by the Government of ...
Mar 26, 2020 07:00 am ET
OTC Markets Group Welcomes Khiron Life Sciences Corp. to OTCQX
NEW YORK, March 26, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Khiron Life Sciences Corp (TSX-V: KHRN; OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America, has qualified to trade on the OTCQX® Best Market. Khiron Life Sciences Corp. upgraded to OTCQX from the OTCQB® Venture Market....
Mar 20, 2020 09:04 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, March 20, 2020 /CNW/ - Trading resumes in:
Mar 20, 2020 08:48 am ET
Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update
Effective immediately, Khiron is fully authorized to manufacture high- and low-THC medical cannabis, and to fill prescriptions for low-THC medical cannabis Khiron anticipates filling its first revenue generating patient prescriptions within days With successful lab certification, Khiron becomes the first company authorized to sell medical cannabis in Colombia Colombia has upwards of 6 million potential patients for medical cannabis products (Source: IMS Quintiles) Khiron also provides a general corporate update and response to Covid-19 TORONTO, March 20, 2020 /PRNewswire/ - Khiron Life Scie...
Mar 20, 2020 08:48 am ET
Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update
Effective immediately, Khiron is fully authorized to manufacture high- and low-THC medical cannabis, and to fill prescriptions for low-THC medical cannabis Khiron anticipates filling its first revenue generating patient prescriptions within days With successful lab certification, Khiron becomes the first company authorized to sell medical cannabis in Colombia Colombia has upwards of 6 million potential patients for medical cannabis products (Source: IMS Quintiles) Khiron also provides a general corporate update and response to Covid-19 TORONTO, March 20, 2020 /CNW/ - Khiron Life Sciences Co
Mar 19, 2020 02:49 pm ET
IIROC Trading Halt - KHRN
VANCOUVER, March 19, 2020 /CNW/ - The following issues have been halted by IIROC:
Mar 05, 2020 05:36 pm ET
Khiron Poised to Enter Medical Cannabis Market in Peru
Signed a 2-year exclusive agreement to manufacture and distribute Khiron-branded medical cannabis products in Lima, Peru´s largest city with 8.6 million inhabitants With 10 locations in Lima, Farmacia Universal S.A.C. is an established magistral formulation laboratory and pharmacy Khiron Perú SA has already obtained certifications as a Pharmaceutical Entity with Good Storage Practices (GSP), a crucial prerequisite for import and commercialization license applications in Peru The Company obtained approval of its security protocols from the Anti-Narcotics Unit of the Ministry of Interior (DIRA
Mar 03, 2020 06:30 am ET
Khiron President Chris Naprawa To Present at 2020 LD Micro Virtual Conference
TORONTO, ON / ACCESSWIRE / March 3, 2020 / Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced today that the Company will be presenting at the third annual LD Micro Virtual Conference on Tuesday March 3rd at 1:40pm PST/4:40pm EST.
Mar 01, 2020 07:56 pm ET
Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia
Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority ("TQG") allows the Company to now produce oils for sale both domestically and abroad. Of the 9.3 tonnes approved, 50% are for Colombian domestic use and 50% are allowed for export purposes. Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay and Brazil, thereby accessing to a medical cannabis market of $1.4 Billion. (Source: New Frontier Data) Domestic quotas represent a further milestone in the C
Feb 27, 2020 06:21 pm ET
Khiron Receives Approval of Normal Course Issuer Bid
TORONTO, Feb. 27, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that, further to its February 11, 2020 press release, the Company has received final approval from the TSX Venture Exchange (the "TSXV") for a normal course issuer bid to repurchase, for cancellation, up to 5,830,615 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding Shares (the "NCIB").
Feb 26, 2020 04:53 pm ET
Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17% of the Total Allocated Quota for Colombia in 2020
Colombia was granted a total production quota of 56.2 tons of medical cannabis for 2020 by the International Narcotics Control Board ("INCB"), the entity responsible for the implementation of the United Nations drug conventions. This represents 21.9% of the world´s legal global supply of high THC medical cannabis. The Company will begin cultivation activities immediately in its existing state-of-the-art facility near Ibague, Colombia, with its already-registered strains. The Company will be notified of the accompanying extraction quota by the Ministry of Health of Colombia, which will define
Feb 20, 2020 07:04 am ET
Khiron Announces Plans to Expand Kuida® Distribution to Spain
Company prepares to bring Kuida CBD brand to Spain with receipt of "no objection" letter from TSXV, subject to complying with all regulatory requirements in Spain As previously announced, Khiron has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida products Expands on previously announced Kuida entry to the UK Company further prepares for Kuida to enter the Swiss market, conditional on TSXV approval, representing a skincare market of US$540 million in 2018 (Source: Euromonitor) Spain skincare market estimated at US$1.7 billion in 2019 (Source: Euromonitor) TORONTO, Feb
Feb 14, 2020 06:00 am ET
Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC
TORONTO, Feb. 14, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce it will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20th, 2020 at the Fairmont Pacific Rim Hotel in Vancouver, BC. 
Feb 11, 2020 06:00 am ET
Khiron Announces Normal Course Issuer Bid
TORONTO, Feb. 11, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces today its intention to commence a normal course issuer bid through the facilities of the TSX Venture Exchange (the "TSXV") to repurchase, for cancellation, up to 5,830,615 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding Shares (the "NCIB"). The NCIB remains subject to the final approval of the TSXV.
Feb 10, 2020 03:30 pm ET
Khiron to Host Investor Webcast Live on February 11, 2020
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations
Feb 07, 2020 06:37 am ET
Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product
Authorization from the Brazilian Health Regulatory Agency (ANVISA) allows for Khiron medical cannabis product to be imported for use on an individual patient basis Authorization follows December 2019 announcement by ANVISA allowing for a new class of medical cannabis-based product to be prescribed by doctors and sold through pharmacies, enabling patient safe and legal access In Colombia, Company prepares for final authorization milestone allowing for domestic medical cannabis distribution Brazil represents the largest addressable market in Latin America with an anticipated 3.4 million patien
Jan 13, 2020 11:05 pm ET
Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic
Innovative clinic establishes new patient-first model for Colombia with the benefits of complementary professional medical services in a single, integrated care environment Clinic features contemporary design across four expansive floors, within 600 metres of Bogota's largest transit hub, and in the city's prime medical services district 15,000 sq. ft clinic offers comprehensive suite of health and medical services in alignment with insurance company partners Zerenia launch follows the successful growth of Company's Ilans neurological clinics Zerenia branded clinic in keeping with Khiron's p
Jan 05, 2020 11:01 pm ET
Khiron CEO Alvaro Torres to Present at AltaCorp/ATB 8th Annual Institutional Investor Conference
TORONTO, Jan. 6, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that CEO and Director Alvaro Torres will speak on the International Expansion panel at the AltaCorp/ATB 8th Annual Institutional Investor Conference at 3:10pm on January 14, 2020. Mr. Torres and other members of the Khiron leadership team will also be conducting one-on-one meetings at the conference, taking place January 14-16, 2020 at the Shangri-La Hotel Toronto.
Dec 29, 2019 11:01 pm ET
Khiron Welcomes Colombia's Receipt of 2020 Production Quota of 56.5 Tons of High-THC Cannabis
Khiron the only LP with a 2019 quota that authorizes the Company to manufacture high-THC whole plant extract and produce customized medical cannabis prescriptions for domestic use 56.5 tons, or 21.84% of global supply of high THC medical cannabis for commercial and scientific purposes assigned to Colombia for 2020 by International Narcotics Control Board ("INCB"), the entity responsible for the implementation of the United Nations drug conventions This permit represents the highest annual cannabis quota in Colombian history, and the world's second largest allocations for 2020, based on a tot
Dec 15, 2019 11:01 pm ET
Khiron Welcomes Regulatory Guidelines in Peru, Announces Good Storage Practices Certification
Peruvian authorities to allow businesses to begin applications for medical cannabis licenses, and further outline a clear licensing process Khiron has secured Good Storage Practices (GSP) certification, a crucial prerequisite for import and commercialization license applications in Peru Company has submitted its security protocols for regulatory review as a further step to securing key licenses With a population of 32 million, Peru's medical cannabis market is estimated to be worth $99 million (Prohibition Partners) Strong cash balance firmly positions Company to capitalize on emerging marke
Dec 03, 2019 11:01 pm ET
Khiron Welcomes Legalization of Medical Cannabis in Brazil
Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential USD $229 Million patient network for medical cannabis (New Frontier Data) Brazilian national health authority (ANVISA) approves the sale of medical cannabis products for sale by prescription and through pharmacies Khiron to participate in Brazil medical cannabis market through the Mercosur Regional Trading Bloc Regulations come into force 90 days after imminent posting on Federal Official Gazette TORONTO, Dec. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Compan
Nov 29, 2019 04:00 pm ET
Khiron Announces Chairman Transition and Appointment of Audit Committee Chair
TORONTO, Nov. 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Sidney Himmel has resigned as Director and Chair of the Board to pursue other interests, effective immediately.
Nov 27, 2019 04:30 pm ET
Khiron Announces Option and Restricted Share Unit Grants
TORONTO, Nov. 27, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced that it has granted stock options and restricted share units (RSUs) to certain directors and officers of the Company and its subsidiaries under the Company's Amended and Restated Stock Option Plan and Amended and Restated RSU Plan. 
Nov 26, 2019 06:00 am ET
Khiron Reports Q3 Fiscal 2019 Financial Results, With $47.9 Million Cash Balance and $2.8 Million in Quarterly Revenue
Ended the quarter with $47.9 million in cash and short-term investments Robust balance sheet puts Company in a position of strength ILANS clinics showed progressively stronger margins and an over 20% increase in revenues in Q3 Multi-country strategy advances with TSX-V approval for distribution and sale of Kuida CBD products in the United States, with sales launched in the US market in November, and;   Approval to sell Aceso hemp CBD brand in Colombia, targeted for entry in Q1 2020 Fulfilled European Union cosmetic product regulatory requirements for seven Kuida products for distribution int
Nov 24, 2019 11:01 pm ET
Khiron Receives First Colombian Authorization to Commercialize High-THC Cannabis for Domestic and Export Sales
Authorization for domestic and export purposes comes as a result of commercial quotas allocated to Khiron by the Colombian Technical Quotas Group ("TQG") for 2019 Permits Company to cultivate and commercialize psychoactive cannabis Includes authorization to export of whole plant extract to Uruguay and Brazil Positions Khiron to as the first LP to manufacture high-THC whole plant extract and produce customized medical cannabis prescriptions for domestic use TORONTO, Nov. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC)
Nov 20, 2019 11:01 pm ET
Khiron Director and 55th President of Mexico, Vicente Fox to Present Keynote at UK Cannabis Investor Conference
TORONTO, Nov. 21, 2019 /CNW/ -  Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Company Director and 55th President of Mexico, Vicente Fox, will present a keynote address at the Bryan, Garnier & Co Cannabis Conference, taking place on Thursday, November 28, 2019 in London, UK.
Nov 18, 2019 11:01 pm ET
Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe's Largest Medical Cannabis Study with 20,000 Patients
Khiron Life Sciences establishes early mover position to build its brand and product offering in the United Kingdom's nascent medical cannabis market Project Twenty21 will study medical cannabis's therapeutic effects on 20,000 patients - and build largest ever evidence base for UK National Health Service (NHS) provision of these medicines Real-world data registry will document patient outcomes in those prescribed medical cannabis and support health authority applications Project welcomed by The Royal College of Psychiatrists, peers, The British Pain Society, United Patients Alliance and lead
Nov 17, 2019 11:01 pm ET
Khiron Launches Kuida Brand in the US, Begins First Sales
First retail sales in US commence in beauty capital of Los Angeles on November 20, targeting US skincare market Initial distribution to include partnership with leading lifestyle media and retail brand Cannabis Now Activation at Cannabis Now's high-traffic Los Angeles location to target affluent, trendy audience of beauty and cannabis consumers Company to support sales through comprehensive marketing and branding campaign, including content to reach Cannabis Now's 4.2M audience Launch to kick off with experiential event on Nov. 20 at Cannabis Now flagship store US skincare market estimated a
Nov 10, 2019 11:01 pm ET
Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia
First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture Builds on proven Aceso brand acceptance across US consumer market Product line includes indication-specific (heat and cool), hemp-derived CBD balms Approval secured from INVIMA for commercialization in Colombia of initial Aceso products, Alfa Balm (heat) and Sigma Balm (cool) Introduction to Colombian market in Q4 2019 with expansion to Chile and Uruguay in 2020 Latin America herbal/traditional topical analgesic and topical analgesics/Anaesthetic market estimated at US$380 million (Source: Euromonitor 2018) ...
Nov 10, 2019 11:01 pm ET
Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia
First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture Builds on proven Aceso brand acceptance across US consumer market Product line includes indication-specific (heat and cool), hemp-derived CBD balms Approval secured from INVIMA for commercialization in Colombia of initial Aceso products, Alfa Balm (heat) and Sigma Balm (cool) Introduction to Colombian market in Q4 2019 with expansion to Chile and Uruguay in 2020 Latin America herbal/traditional topical analgesic and topical analgesics/Anaesthetic market estimated at US$380 million (Source: Euromonitor 2018)
Nov 05, 2019 11:01 pm ET
Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market
Clinical research partnership with Centro Dermatológico Federico Lleras Acosta (CDFLLA), focuses on effectiveness of medical cannabis for dermatological conditions defined in three main lines of research: Melanoma, Keratinocytes and Mycobacterial growth. Lines of research presented November 2, 2019 at II TeraCILAD dermatological conference with more than 1,000 LATAM dermatologists in attendance. Research initiated by Khiron and CDFLLA anticipated to begin in Q1 2020, representing first of its kind in Latin America Global dermatological (prescription) drug market valued at $38.4bn in 2017, ri
Nov 05, 2019 11:01 pm ET
Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market
Clinical research partnership with Centro Dermatológico Federico Lleras Acosta (CDFLLA), focuses on effectiveness of medical cannabis for dermatological conditions defined in three main lines of research: Melanoma, Keratinocytes and Mycobacterial growth. Lines of research presented November 2, 2019 at II TeraCILAD dermatological conference with more than 1,000 LATAM dermatologists in attendance. Research initiated by Khiron and CDFLLA anticipated to begin in Q1 2020, representing first of its kind in Latin America Global dermatological (prescription) drug market valued at $38.4bn in 2017, ri...
Nov 03, 2019 11:01 pm ET
Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D
TORONTO, Nov. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately.
Nov 03, 2019 11:01 pm ET
Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D
TORONTO, Nov. 4, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately....
Nov 01, 2019 12:01 am ET
Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference
Company will present to institutional investors and join panel discussions covering developments in the cannabis industry...
Nov 01, 2019 12:01 am ET
Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference
Company will present to institutional investors and join panel discussions covering developments in the cannabis industry
Oct 31, 2019 12:01 am ET
Khiron to Host Live Investor Webcast on November 5, 2019
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentation
Oct 31, 2019 12:01 am ET
Khiron to Host Live Investor Webcast on November 5, 2019
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentation...
Oct 25, 2019 12:01 am ET
Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia
First import of Kuida products into the US now completed, with launch and sales to start in November 2019 E.U. cosmetic product regulatory requirements fulfilled for seven Kuida products, with commercialization in U.K. set for Q1 2020 New distribution agreements secured in Colombia, bringing total points-of-sale to 300+ Multi-channel distribution strategy rapidly advances to target US$135 billion global skincare market TORONTO, Oct. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis lea
Oct 25, 2019 12:01 am ET
Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia
First import of Kuida products into the US now completed, with launch and sales to start in November 2019 E.U. cosmetic product regulatory requirements fulfilled for seven Kuida products, with commercialization in U.K. set for Q1 2020 New distribution agreements secured in Colombia, bringing total points-of-sale to 300+ Multi-channel distribution strategy rapidly advances to target US$135 billion global skincare market TORONTO, Oct. 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated canna...
Oct 16, 2019 12:30 am ET
Khiron Participates in Mexican Senate Cannabis Regulation Forum
Mexico poised to become the largest market in the world to fully legalize cannabis nationwideForum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico – currently expected by the end of October 2019Builds on Khiron's history of leadership and advocacy in Mexico's developing cannabis industry Company holds close relationships with key stakeholders in Mexico, including former president of Mexico and current Khiron board member Vicente Fox, as well as medical associations across the country Company positioned to play a leading role in the Mexican...
Oct 16, 2019 12:30 am ET
Khiron Participates in Mexican Senate Cannabis Regulation Forum
Mexico poised to become the largest market in the world to fully legalize cannabis nationwideForum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico – currently expected by the end of October 2019Builds on Khiron's history of leadership and advocacy in Mexico's developing cannabis industry Company holds close relationships with key stakeholders in Mexico, including former president of Mexico and current Khiron board member Vicente Fox, as well as medical associations across the country Company positioned to play a leading role in the Mexican
Oct 15, 2019 12:01 am ET
Khiron to Commercialize Kuida® Brand in U.K.
Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® products Initial UK import anticipated for Q4 2019 Company has received a "no objection" letter from TSXV for distribution of the Kuida products in the UK UK skincare market estimated at US$3.8 billion in 2018 (Source: Euromonitor) TORONTO, Oct. 15, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated c
Oct 15, 2019 12:01 am ET
Khiron to Commercialize Kuida® Brand in U.K.
Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® products Initial UK import anticipated for Q4 2019 Company has received a "no objection" letter from TSXV for distribution of the Kuida products in the UK UK skincare market estimated at US$3.8 billion in 2018 (Source: Euromonitor) TORONTO, Oct. 15, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integ...
Oct 08, 2019 12:01 am ET
Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK
TORONTO, Oct. 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019.
Oct 08, 2019 12:01 am ET
Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK
TORONTO, Oct. 8, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019....
Sep 26, 2019 12:01 am ET
Khiron to Present and Host Attendees at First MJBizDaily Latin American Cannabis Symposium
Symposium brings together industry leaders, investors and policy decision-makers for two-day event spotlighting the potential of the Latin American cannabis industry CEO and Director Alvaro Torres and Skin Unit Director Elsa Navarro to participate in panels covering cannabis investing & finance and CBD cosmetics topics Latin America positioned to be a vital player in global cannabis industry, valued at an estimated US$12 Billion within the next decade (Source Prohibition Partners) TORONTO, Sept. 26, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN),...
Sep 26, 2019 12:01 am ET
Khiron to Present and Host Attendees at First MJBizDaily Latin American Cannabis Symposium
Symposium brings together industry leaders, investors and policy decision-makers for two-day event spotlighting the potential of the Latin American cannabis industry CEO and Director Alvaro Torres and Skin Unit Director Elsa Navarro to participate in panels covering cannabis investing & finance and CBD cosmetics topics Latin America positioned to be a vital player in global cannabis industry, valued at an estimated US$12 Billion within the next decade (Source Prohibition Partners) TORONTO, Sept. 26, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB
Sep 25, 2019 12:01 am ET
Khiron Secures Approval to Sell Three More CBD Wellness Products
Approval to sell three additional Kuida® CBD products focused on anti-aging, hydration and everyday skin care Expands revenue generating Kuida® cosmeceutical portfolio to 10 SKU´s First sales expected in Q4 for the newly approved products Kuida® portfolio first INVIMA-approved branded CBD beauty product in Colombia TORONTO, Sept. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval from IN
Sep 25, 2019 12:01 am ET
Khiron Secures Approval to Sell Three More CBD Wellness Products
Approval to sell three additional Kuida® CBD products focused on anti-aging, hydration and everyday skin care Expands revenue generating Kuida® cosmeceutical portfolio to 10 SKU´s First sales expected in Q4 for the newly approved products Kuida® portfolio first INVIMA-approved branded CBD beauty product in Colombia TORONTO, Sept. 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval ...
Sep 11, 2019 08:35 am ET
/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Sep 10, 2019 08:30 am ET
Khiron To Webcast Live At VirtualInvestorConferences.com On September 12th
TORONTO, Sept. 10, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that Khiron CEO, Alvaro Torres will present life at VirtualInvestorConferences.com on September 12th....
Sep 06, 2019 09:15 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th
NEW YORK, Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET, with the first live webcast at 9:30 AM ET, on Thursday, September 12th....
Sep 04, 2019 12:01 am ET
Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
Facility in Juan Lacaze includes GAP-compliant 8,000 m2 (86,111 sq.ft) cultivation area and a GMP-compliant 1,800 m2 (19,375 sq.ft) processing plant, with a production capacity of 17 tons per year Increases Khiron's total production capacity and strengthens ability to export and supply cannabis across the Mercosur trading bloc, with access to Brazil and Europe Medical cannabis markets in Brazil and Europe are expected to be respectively worth $144.3 billion USD and €115.7 Billion by 2028 (Source: Prohibition Partners) Construction scheduled for completion in mid Q3 2020 TORONTO, Sept. 4, 20
Sep 04, 2019 12:01 am ET
Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
Facility in Juan Lacaze includes GAP-compliant 8,000 m2 (86,111 sq.ft) cultivation area and a GMP-compliant 1,800 m2 (19,375 sq.ft) processing plant, with a production capacity of 17 tons per year Increases Khiron's total production capacity and strengthens ability to export and supply cannabis across the Mercosur trading bloc, with access to Brazil and Europe Medical cannabis markets in Brazil and Europe are expected to be respectively worth $144.3 billion USD and €115.7 Billion by 2028 (Source: Prohibition Partners) Construction scheduled for completion in mid Q3 2020 TORONTO, Sept. 4, 20...
Aug 29, 2019 12:01 am ET
Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics
Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression or are in palliative care (Source: IMS quintiles) Khiron medical product pipeline focused on priority conditions associated with aging, including chronic pain management Khiron neurologist Paula Martinez to present keynote to more than 1,500 health professionals at Association congress in Cali, Colombia Endorsement will advance Company strategy to meet the priority needs of over 68 million ...
Aug 29, 2019 12:01 am ET
Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics
Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression or are in palliative care (Source: IMS quintiles) Khiron medical product pipeline focused on priority conditions associated with aging, including chronic pain management Khiron neurologist Paula Martinez to present keynote to more than 1,500 health professionals at Association congress in Cali, Colombia Endorsement will advance Company strategy to meet the priority needs of over 68 million
Aug 26, 2019 07:00 am ET
Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results
Advances multi-country operator strategy with acquisition of NettaGrowth, securing first medical THC and CBD cannabis license and cultivation capacity in Uruguay, and potential for access to Brazilian market Closes $28,751,035 bought deal financing, including full exercise of over-allotment option Completed the quarter with $55.8 million in cash Expands distribution for Kuida cosmeceutical brand, signing distribution agreements with Fedco, Linio, Cafam – large consumer distribution channels in Colombia. Subsequent to the quarter signed distribution agreement with Grupo Exito, one of South Am...
Aug 26, 2019 07:00 am ET
Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results
Advances multi-country operator strategy with acquisition of NettaGrowth, securing first medical THC and CBD cannabis license and cultivation capacity in Uruguay, and potential for access to Brazilian market Closes $28,751,035 bought deal financing, including full exercise of over-allotment option Completed the quarter with $55.8 million in cash Expands distribution for Kuida cosmeceutical brand, signing distribution agreements with Fedco, Linio, Cafam – large consumer distribution channels in Colombia. Subsequent to the quarter signed distribution agreement with Grupo Exito, one of South Am
Aug 22, 2019 12:01 am ET
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testingPhysical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples State-of-the-art testing la...
Aug 22, 2019 12:01 am ET
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testingPhysical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples State-of-the-art testing la
Aug 20, 2019 12:01 am ET
Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors
TORONTO, Aug. 20, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States....
Aug 20, 2019 12:01 am ET
Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors
TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
Aug 14, 2019 09:00 pm ET
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. ...
Aug 14, 2019 09:00 pm ET
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019.
Aug 12, 2019 12:01 am ET
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal Officer for Khiron Europe Both executives join Khiron from one of the world's largest cannabis companies Region's medical cannabis industry estimated to be worth €115.7 Billion by 2028 (Prohibition Partners) TORONTO, Aug. 12, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with cor...
Aug 12, 2019 12:01 am ET
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal Officer for Khiron Europe Both executives join Khiron from one of the world's largest cannabis companies Region's medical cannabis industry estimated to be worth €115.7 Billion by 2028 (Prohibition Partners) TORONTO, Aug. 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core opera
Aug 08, 2019 12:01 am ET
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate of Suramericana S.A., one of Latin America's largest insurance companies with a presence in nine countries including Mexico, Chile and Uruguay Pilot program between EPS SURA and ILANS will leverage both parties' resources to enhance patient access to integrated healthcare management models Pilot program forms basis of model to generate predictable and recurring revenue for the Company Furt...
Aug 08, 2019 12:01 am ET
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate of Suramericana S.A., one of Latin America's largest insurance companies with a presence in nine countries including Mexico, Chile and Uruguay Pilot program between EPS SURA and ILANS will leverage both parties' resources to enhance patient access to integrated healthcare management models Pilot program forms basis of model to generate predictable and recurring revenue for the Company Furt
Aug 07, 2019 12:01 am ET
Khiron Signs Kuida Distribution Agreement with Grupo Éxito, South America's Market Leading Retail Group
Distribution agreement with Grupo Éxito includes initial Kuida presence in 5 key market Éxito WOW concept stores and 16 Éxito traditional format stores with a potential expansion planned across Colombia.  Grupo Éxito has a multinational retail presence in Colombia, Brazil, Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness. Accelerates Company's multi-channel brand distribution strategy targeting U.S. $7.9 bil...
Aug 07, 2019 12:01 am ET
Khiron Signs Kuida Distribution Agreement with Grupo Éxito, South America's Market Leading Retail Group
Distribution agreement with Grupo Éxito includes initial Kuida presence in 5 key market Éxito WOW concept stores and 16 Éxito traditional format stores with a potential expansion planned across Colombia.  Grupo Éxito has a multinational retail presence in Colombia, Brazil, Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness. Accelerates Company's multi-channel brand distribution strategy targeting U.S. $7.9 bil
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("K...
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron")
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("K...
Aug 01, 2019 04:30 pm ET
Khiron Provides Update on Canapalife Group Transaction
TORONTO, Aug. 1, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, today provided an update on the Company's previously announced non-binding LOI with Canapalife Group. The Company confirms the expiry of the LOI and that the parties have mutually agreed not to proceed with the proposed transaction. ...
Aug 01, 2019 04:30 pm ET
Khiron Provides Update on Canapalife Group Transaction
TORONTO, Aug. 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, today provided an update on the Company's previously announced non-binding LOI with Canapalife Group. The Company confirms the expiry of the LOI and that the parties have mutually agreed not to proceed with the proposed transaction.
Aug 01, 2019 12:01 am ET
Khiron Begins Pre-clinical Medical Cannabis Studies with Leading Academic Institutes in Uruguay
Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company strains, 18-month studies represent one of the most significant private-public medical cannabis initiatives in Latin America Project awarded matching financing support by Uruguay government for its medical innovation Uruguay market provides direct strategic opportunity of 3 million patients for medical cannabis with potential entry to Brazil, Argentina and Paraguay under Mercosur trade bloc ...
Aug 01, 2019 12:01 am ET
Khiron Begins Pre-clinical Medical Cannabis Studies with Leading Academic Institutes in Uruguay
Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company strains, 18-month studies represent one of the most significant private-public medical cannabis initiatives in Latin America Project awarded matching financing support by Uruguay government for its medical innovation Uruguay market provides direct strategic opportunity of 3 million patients for medical cannabis with potential entry to Brazil, Argentina and Paraguay under Mercosur trade bloc
Jul 30, 2019 05:55 pm ET
Khiron Announces Final Approval of Acquisition of NettaGrowth
TORONTO, July 30, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company has received final approval from the TSX Venture Exchange ("TSXV") to close its previously announced acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which owns all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"). As consideration for the Acquisition, Khiron issued 8,498,821 common shares to the shareholders o
Jul 30, 2019 05:55 pm ET
Khiron Announces Final Approval of Acquisition of NettaGrowth
TORONTO, July 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company has received final approval from the TSX Venture Exchange ("TSXV") to close its previously announced acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which owns all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"). As consideration for the Acquisition, Khiron issued 8,498,821 common shares to the shareho...
Jul 25, 2019 12:01 am ET
Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index, which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries. ...
Jul 25, 2019 12:01 am ET
Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index, which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries.
Jul 17, 2019 12:01 am ET
Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute
Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Commercial sales expected for third quarter of 2019 Initial harvest expected to produce CBD extract in 2019 to supply Khiron´s established medical cannabis distribution channel of over 1.0 million potential patients Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). Production includes full profile of CBD and THC strains specifically selected for key target indications Khiron will now seek commercial quota for the commercializ...
Jul 17, 2019 12:01 am ET
Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute
Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Commercial sales expected for third quarter of 2019 Initial harvest expected to produce CBD extract in 2019 to supply Khiron´s established medical cannabis distribution channel of over 1.0 million potential patients Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). Production includes full profile of CBD and THC strains specifically selected for key target indications Khiron will now seek commercial quota for the commercializ
Jul 16, 2019 12:01 am ET
Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America
Full portfolio of Kuida products will be exhibited at the event's Discover Beauty Pavilion to over 40,000 retail buyers, distributors, and beauty industry professionals Kuida is the first Colombian mass-market CBD cosmeceutical brand to showcase at Cosmoprof Participation in Cosmoprof North America marks crucial step towards expansion of Kuida into the United States, subject to TSX approval, targeting $20 billion dollar U.S. cosmetic market (Euromonitor) Further solidifies strong relationship between Kuida and a growing network of retailers, distributors and buyers, as the brand continues to
Jul 16, 2019 12:01 am ET
Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America
Full portfolio of Kuida products will be exhibited at the event's Discover Beauty Pavilion to over 40,000 retail buyers, distributors, and beauty industry professionals Kuida is the first Colombian mass-market CBD cosmeceutical brand to showcase at Cosmoprof Participation in Cosmoprof North America marks crucial step towards expansion of Kuida into the United States, subject to TSX approval, targeting $20 billion dollar U.S. cosmetic market (Euromonitor) Further solidifies strong relationship between Kuida and a growing network of retailers, distributors and buyers, as the brand continues to...
Jul 15, 2019 12:01 am ET
Khiron Provides Corporate Update on Commercial and Operational Activities
Colombia commercial production anticipated to be commercialized in Q3. All cultivation, extraction and testing facilities operating and in optimal condition Potential addressable patient network of over 1 million individuals, represented by over 5,000 doctors through six medical association endorsements Core medical cannabis distribution channels secured with arrangement for over 900 retail locations Wellness line secured distribution agreements with largest retails of product category throughout Colombia, across 176 points of sale. Commenced jurisdictional and product portfolio expansion Cu
Jul 15, 2019 12:01 am ET
Khiron Provides Corporate Update on Commercial and Operational Activities
Colombia commercial production anticipated to be commercialized in Q3. All cultivation, extraction and testing facilities operating and in optimal condition Potential addressable patient network of over 1 million individuals, represented by over 5,000 doctors through six medical association endorsements Core medical cannabis distribution channels secured with arrangement for over 900 retail locations Wellness line secured distribution agreements with largest retails of product category throughout Colombia, across 176 points of sale. Commenced jurisdictional and product portfolio expansion Cu...
Jul 09, 2019 12:30 am ET
Khiron CEO Alvaro Torres to Present at 2019 Canaccord Genuity U.S. Annual Growth Conference
Company Invited to Particpate in Strategic US Investor Conference...
Jul 09, 2019 12:30 am ET
Khiron CEO Alvaro Torres to Present at 2019 Canaccord Genuity U.S. Annual Growth Conference
Company Invited to Particpate in Strategic US Investor Conference
Jul 08, 2019 12:30 am ET
Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico
Khiron was the sole cannabis company to present during the four-day symposium organized by the Mexican College of Internal Medicine Event participation builds upon Khiron's relationship with the Mexican College of Internal Medicine, a leading association of internal medicine specialists that previously endorsed the company in 2018 Conference attendees included over 2000 leading specialists, physicians and healthcare professionals from across Mexico TORONTO, July 8, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with co...
Jul 08, 2019 12:30 am ET
Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico
Khiron was the sole cannabis company to present during the four-day symposium organized by the Mexican College of Internal Medicine Event participation builds upon Khiron's relationship with the Mexican College of Internal Medicine, a leading association of internal medicine specialists that previously endorsed the company in 2018 Conference attendees included over 2000 leading specialists, physicians and healthcare professionals from across Mexico TORONTO, July 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core oper
Jul 03, 2019 08:35 am ET
Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Jul 03, 2019 08:35 am ET
Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing
NEW YORK, July 3, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Grit Capital, today announced that the presentations from our recent virtual event are now available for on-demand viewing. Eight public & private company executives provided insight on innovation, consolidation, international expansion and specialization in millennial investment industries. Login to now to watch the presentations and hear answers to questions from the audience....
Jul 01, 2019 12:30 am ET
Khiron Welcomes EU Trade Deal with Latin American Countries
TORONTO, July 1, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina, Brazil, Uruguay and Paraguay. Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay....
Jul 01, 2019 12:30 am ET
Khiron Welcomes EU Trade Deal with Latin American Countries
TORONTO, July 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina, Brazil, Uruguay and Paraguay. Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay.
Jun 25, 2019 12:05 am ET
Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference
TORONTO, June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, announces today that Company president Chris Naprawa will be presenting at the Grit Capital Virtual Investor Conference to be hosted on June 26, 2019.
Jun 21, 2019 12:50 pm ET
Grit Capital's Live-Stream Virtual Investor Conference June 26th
9 Company Executives of small cap millennial themed companies share their vision and answer questions live at VirtualInvestorConferences.com
Jun 19, 2019 12:05 am ET
Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy
The Acquisition of NettaGrowth International Inc. provides Khiron with up to an additional 120 tonnes of licenced production capacity Diversifies Khiron´s licence composition to include medical use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Mr. Joseph Mimran, experienced brand builder and entrepreneur, joins the board of Khiron Colombia S.A.S TORONTO, June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHR
Jun 14, 2019 06:56 am ET
Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO
TORONTO, June 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced the appointment of Wendy Kaufman as CFO, effective July 2, 2019. Ms. Kaufman, a Chartered Professional Accountant, brings over 20 years of international financial experience, having served most recently as CFO at Pasinex Resources Limited.  Ms. Kaufman has significant experience with Latin American operations, gained during her tenure as CFO at Primero Mining Corporation, and previous
Jun 07, 2019 12:01 am ET
Khiron Receives Regulatory Approval for Uruguay Acquisition
TORONTO, June 7, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned.
Jun 06, 2019 08:35 am ET
Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Jun 03, 2019 08:07 am ET
/R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year/
TORONTO, June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country.
Jun 02, 2019 05:58 pm ET
Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year
TORONTO, June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country.
May 31, 2019 08:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
May 30, 2019 09:20 pm ET
Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results
Expands to second jurisdiction on closing of agreement with Dayacann to enter Chilean medical cannabis market
May 29, 2019 12:05 am ET
Khiron Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF
TORONTO, May 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its addition to the MJ ETFMG Alternative Harvest ETF (NYSE:MJ) (the "Fund"), a fund with approximately US$1.22 billion in assets currently under management. This represents an important development for the Company as it advances its strategy as a Latin American cannabis company with global growth.
May 28, 2019 10:19 am ET
Khiron Announces Closing of $28.75 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
May 13, 2019 04:30 pm ET
Khiron Provides Update on Transaction to Acquire NettaGrowth
TORONTO, May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of th
May 10, 2019 06:54 pm ET
Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders
Annual General and Special Meeting of Shareholders scheduled for May 31, 2019 at 11 a.m. (Toronto time). Proxy voting deadline is May 29, 2019 at 11 a.m. (Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO, May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials"
May 06, 2019 05:12 pm ET
Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
May 01, 2019 08:00 am ET
Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update
Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution Became the first Colombian cannabis company to list on the TSX Venture Exchange Geographic footprint to countries including Colombia, Mexico, Chile, Peru, Uruguay and Italy Received first INVIMA approvals for seven CBD-based cosmeceutical products in Colombia. Generated first revenue in Q4 2018 with the commercialization of the Kuida® brand of cosmeceutical products Increased potential cultivation capacity to 220 tonnes per annum through organic growth and pending a
Apr 30, 2019 12:05 am ET
Khiron Gets Kuida® Into Another 150 Stores
Distribution agreement with Cafam includes initial Kuida® product orders for 49 points of sale Further expansion to increase to 150 stores in first 6 months Cafam operates total of 270 stores across over 60 market in Colombia Accelerates Company's multi-channel brand distribution strategy targeting $10 Billion Latin American skincare market TORONTO, April 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a di...
Apr 30, 2019 12:05 am ET
Khiron Gets Kuida® Into Another 150 Stores
Distribution agreement with Cafam includes initial Kuida® product orders for 49 points of sale Further expansion to increase to 150 stores in first 6 months Cafam operates total of 270 stores across over 60 market in Colombia Accelerates Company's multi-channel brand distribution strategy targeting $10 Billion Latin American skincare market TORONTO, April 30, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a distribut
Apr 29, 2019 12:05 am ET
Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia
LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated that the arrangement will ensure critical infrastructure for Khiron to distribute its made-to-order pharmaceutical compounds to more than 5 million potential patients (Source: Quintiles IMS) in Colombia Upon execution of a definitive agreement, Khiron expects to establish Colombia's most advanced distribution platform for medical cannabis products Provides ease of access at pharmacy stores and
Apr 29, 2019 12:05 am ET
Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia
LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated that the arrangement will ensure critical infrastructure for Khiron to distribute its made-to-order pharmaceutical compounds to more than 5 million potential patients (Source: Quintiles IMS) in Colombia Upon execution of a definitive agreement, Khiron expects to establish Colombia's most advanced distribution platform for medical cannabis products Provides ease of access at pharmacy stores and...
Apr 25, 2019 11:40 am ET
Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group
TORONTO, April 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. and 100% of the economic interest in Campodoro S.r.l. ("Canapalife Group") from Alvaro Garro and Paolo Puggioni (the "Vendors"), being the sole shareholders of Canapalife Group....
Apr 25, 2019 11:40 am ET
Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group
TORONTO, April 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. and 100% of the economic interest in Campodoro S.r.l. ("Canapalife Group") from Alvaro Garro and Paolo Puggioni (the "Vendors"), being the sole shareholders of Canapalife Group.
Apr 17, 2019 12:05 am ET
Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Ex
Appointment of Mr. Holifield enhances Khiron's Mexico security and compliance capabilities and operational network Mr. Holifield joins a growing team for Mexico that includes country manager, Luis Chaves, and Mr. Vicente Fox, former Mexican president and Khiron board member Company taking leadership position in Mexico as co-host of Cannamexico World Summit 2019, April 25-26, a medical, regulatory and industry cannabis conference with over 2,000 attendees from ten countries, making it the largest of its kind in the region Appointment expands on Company's stated multi-market growth strategy wi...
Apr 17, 2019 12:05 am ET
Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Ex
Appointment of Mr. Holifield enhances Khiron's Mexico security and compliance capabilities and operational network Mr. Holifield joins a growing team for Mexico that includes country manager, Luis Chaves, and Mr. Vicente Fox, former Mexican president and Khiron board member Company taking leadership position in Mexico as co-host of Cannamexico World Summit 2019, April 25-26, a medical, regulatory and industry cannabis conference with over 2,000 attendees from ten countries, making it the largest of its kind in the region Appointment expands on Company's stated multi-market growth strategy wi
Apr 10, 2019 10:54 am ET
The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  
Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one...
Apr 10, 2019 10:48 am ET
Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market
Anticipated to materially advance efforts to meet consumer needs in the global $131 Billion USD skincare market (Source: Euromonitor International) First-ever cannabis clinical research study initiated in Latin America key to developing new dermo cosmetic and dermatological product lines for Khiron Skin Unit and strengthen Kuida® portfolio First mover advantage in development of dermo cosmetic products with cannabis worldwide Entered into multi-year agreement with Centro Dermatológico Federico Lleras Acosta (CDFLLA), leading Latin American institution, to jointly conduct medical cannabis res
Apr 10, 2019 10:48 am ET
Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market
Anticipated to materially advance efforts to meet consumer needs in the global $131 Billion USD skincare market (Source: Euromonitor International) First-ever cannabis clinical research study initiated in Latin America key to developing new dermo cosmetic and dermatological product lines for Khiron Skin Unit and strengthen Kuida® portfolio First mover advantage in development of dermo cosmetic products with cannabis worldwide Entered into multi-year agreement with Centro Dermatológico Federico Lleras Acosta (CDFLLA), leading Latin American institution, to jointly conduct medical cannabis res...
Apr 09, 2019 10:03 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, April 9, 2019 /CNW/ - Trading resumes in:
Apr 09, 2019 09:50 am ET
Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay
Upon completion of the Acquisition of NettaGrowth International Inc., Khiron´s total production capacity is expected to increase to up to 220 tonnes Diversifies Khiron´s licence composition to include adult use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Concurrent with closing, Mr. Michael Beck, experienced capital markets professional and entrepreneur, to join the board of Khiron, and Mr. Joseph Mimran, experienced brand builder and entre...
Apr 09, 2019 09:50 am ET
Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay
Upon completion of the Acquisition of NettaGrowth International Inc., Khiron´s total production capacity is expected to increase to up to 220 tonnes Diversifies Khiron´s licence composition to include adult use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Concurrent with closing, Mr. Michael Beck, experienced capital markets professional and entrepreneur, to join the board of Khiron, and Mr. Joseph Mimran, experienced brand builder and entre
Apr 09, 2019 08:56 am ET
IIROC Trading Halt - KHRN
VANCOUVER, April 9, 2019 /CNW/ - The following issues have been halted by IIROC:
Apr 08, 2019 07:11 am ET
Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico
Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for the Company in Mexico Rodrigo Azócar appointed Country Manager for Chile, to lead Company's market development and patient association strategy Rodrigo Durán appointed to lead previously announced Dixie Brands joint venture to bring Dixie's 100+ market-leading products to Latin America New hires bring Company employee count to 200+ across its four jurisdictions TORONTO, April 8, 2019 /PRNewswire/ - Kh...
Apr 08, 2019 07:11 am ET
Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico
Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for the Company in Mexico Rodrigo Azócar appointed Country Manager for Chile, to lead Company's market development and patient association strategy Rodrigo Durán appointed to lead previously announced Dixie Brands joint venture to bring Dixie's 100+ market-leading products to Latin America New hires bring Company employee count to 200+ across its four jurisdictions TORONTO, April 8, 2019 /CNW/ - Khiron Li
Apr 04, 2019 12:05 am ET
Khiron Life Sciences Hosts Canadian Pavilion at Cannamexico World Summit 2019, Targeting over 2,000 Global Cannabusiness Leaders
One of the largest and most influential cannabis conferences in Latin America Two-day conference to attract over 2,000 attendees from more than ten countries First Canadian Pavilion welcomes prominent Canadian and global cannabis industry leaders Canadian Pavilion partners include MNP, Cardiol Therapeutics Inc., BMO and Dixie Brands. As previously announced, Dixie Brands and Khiron have established a joint venture to bring Dixie Brands' 100+ category-leading SKU's to the Latin American marketplace Summit co-hosted by Vicente Fox, 55th President of Mexico, former CEO of Coca-Cola Mexico and K
Apr 04, 2019 12:05 am ET
Khiron Life Sciences Hosts Canadian Pavilion at Cannamexico World Summit 2019, Targeting over 2,000 Global Cannabusiness Leaders
One of the largest and most influential cannabis conferences in Latin America Two-day conference to attract over 2,000 attendees from more than ten countries First Canadian Pavilion welcomes prominent Canadian and global cannabis industry leaders Canadian Pavilion partners include MNP, Cardiol Therapeutics Inc., BMO and Dixie Brands. As previously announced, Dixie Brands and Khiron have established a joint venture to bring Dixie Brands' 100+ category-leading SKU's to the Latin American marketplace Summit co-hosted by Vicente Fox, 55th President of Mexico, former CEO of Coca-Cola Mexico and K...
Apr 03, 2019 12:05 am ET
Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia's Top Specialist Beauty Retailer And Linio, Latin America's Largest Online E-Retailer
Retail distribution with Fedco, the first and most established specialized beauty retailer in Colombia, with 22 stores expanding reach to 50% of Colombia's territory Online distribution secured with Colombian e-retailer Linio, controlled by Grupo SACI Falabella, the largest retailer in Latin America with approximately US$15 billion in revenue in 2017 Increases Kuida® brand retail exposure to 78 store locations and approximately 600,000 monthly e-commerce visitors New agreements demonstrate continued first-mover advantage following successful initial Farmatodo product launch TORONTO, April 3...
Apr 03, 2019 12:05 am ET
Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia's Top Specialist Beauty Retailer And Linio, Latin America's Largest Online E-Retailer
Retail distribution with Fedco, the first and most established specialized beauty retailer in Colombia, with 22 stores expanding reach to 50% of Colombia's territory Online distribution secured with Colombian e-retailer Linio, controlled by Grupo SACI Falabella, the largest retailer in Latin America with approximately US$15 billion in revenue in 2017 Increases Kuida® brand retail exposure to 78 store locations and approximately 600,000 monthly e-commerce visitors New agreements demonstrate continued first-mover advantage following successful initial Farmatodo product launch TORONTO, April 3
Apr 01, 2019 07:00 am ET
Khiron Life Sciences President Chris Naprawa to Present at BMO 2019 Cannabis Conference
TORONTO, April 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the BMO 2019 Cannabis Conference, taking place April, 4th, 2019 in Toronto.
Mar 28, 2019 08:00 am ET
CBD is Heading South; Hemp/CBD Markets Spreading into Mexico and South America
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how, as CBD gains momentum in the US, companies are eyeing the next potential markets; mainly south of the border in Mexico and...
Mar 28, 2019 07:36 am ET
Khiron VP of Compliance Matt Murphy to Represent Company on U.S. National Cannabis Roundtable With John Boehner, Former Speaker of the U.S. House of Representatives
Matt Murphy, Khiron Vice President of Compliance, and former DEA Chief of Pharmaceutical Investigations recognized for long-time global advocacy and expertise on regulated cannabis markets around the world with appointment to represent Company on National Cannabis Roundtable Representation of Khiron in expanding on its advocacy for functioning global cannabis markets based on fulsome regulation product systems and controls John Boehner, former US Speaker of the House Representatives, will serve as Honorary Chairman of the National Cannabis Roundtable TORONTO, March 28, 2019 /CNW/ - Khiron
Mar 22, 2019 08:00 am ET
Vertically Integrated Cannabis Companies on Tour: A New Era of Confidence as Regulations Change
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how companies are expanding their footprint and vertical integrated operations. In parallel, management is on the road, spreading...
Mar 14, 2019 02:00 am ET
Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market
Dixie Khiron JV Corp. formally established to bring Dixie Brands portfolio of cannabis-infused products to Latin America Dixie and Khiron are 50/50 JV co-owners JV introduces Khiron's Kuida® brand to the U.S. market, with special focus on the Hispanic population of almost 60 million JV has full access to Dixie's portfolio of more than 100 SKUs sold over the past 9 years in world's most mature cannabis markets Dixie-Khiron to enjoy first-mover advantage in Latin American market of 620 million people LatAm cannabis market estimated to reach $12 billion by 2028 (source: Prohibition Partners) D
Mar 13, 2019 07:00 am ET
Khiron Life Sciences Expands Skincare Leadership Team With The Appointment Of Dr. Edwin Bendek as Medical Director, Skincare
Appointment further strengthens commercial skincare business where Company was first to launch products into Colombia market in 2018 Skincare unit targets $10 Billion Latin America skincare market Dr. Bendek a recognized pioneer in CBD cosmeceutical product innovation Appointment expands expertise in general dermatology, cutaneous surgery, anti-aging dermatology and predictive genetics with appointment of Dr. Bendek TORONTO, March, 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leade
Mar 12, 2019 08:51 am ET
Khiron Life Sciences President Chris Naprawa To Present at 2019 LD Micro Virtual Conference
TORONTO, March 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the second annual LD Micro Virtual Conference on March 13th at 12:20pm EDT.
Mar 12, 2019 08:00 am ET
THC to CBD: More Cannabis Companies Expand Their CBD Capabilities
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019. Every...
Mar 08, 2019 08:00 am ET
CBD Products Coming to a Store near You; CBD Companies Expand Reach
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the flurry of new distribution and marketing deals within the CBD sector, opening up product availability to a growing consumer...
Mar 05, 2019 08:14 am ET
Khiron Introduces Kuida®, First Colombian CBD Cosmeceutical brand At Cosmoprof Worldwide Bologna, Targeting 200,000 Potential Global Retail Buyers
Kuida® introduced as first Colombian mass-market CBD Cosmeceutical brand at Cosmoprof Event attracts up to 200,000 global retail buyers (Source: BolognaFiere Group ) Khiron Skin Unit Director to speak on CBD-based cosmetics expert panel Global skincare market expected to reach US$131 Billion in 2019 TORONTO, March 5, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will participate in Cosmoprof Worldwide Bologna
Mar 04, 2019 08:30 am ET
MEDIA ADVISORY: Khiron Life Sciences and CentroFox Host Cannamexico World Summit Toronto Reception and Q&A With Former Mexican President Vicente Fox
TORONTO, March 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will host a Toronto reception on Thursday, March 7 to announce Cannamexico World Summit 2019, one of the largest and most influential cannabis conferences in Latin America. The Toronto reception will introduce the summit agenda, the first Canadian Pavilion and feature an exclusive on-stage Q&A with Mr. Vicente Fox, the 55th President of Mexico
Feb 28, 2019 09:22 am ET
Khiron Announces Closing of $28.84 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Feb 20, 2019 09:05 am ET
Three of the Best Ways to Invest in Colombia's Fast-Growing Medical Marijuana Market
HOUSTON, TX / ACCESSWIRE / February 20, 2019 / Colombia is on its way to becoming one of the largest global exporters of medical marijuana.
Feb 19, 2019 09:34 am ET
IIROC Trading Halt - KHRN
VANCOUVER, Feb. 19, 2019 /CNW/ - The following issues have been halted by IIROC:
Feb 19, 2019 09:29 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Feb. 19, 2019 /CNW/ - Trading resumes in:
Feb 14, 2019 08:58 am ET
Top 3 Cannabis Stocks Higher on Colombian Growth Story
HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. In time, growers estimate that the country could capture as much as a fifth of a global market that could be worth $40 billion a year, according to Reuters.
Feb 08, 2019 08:00 am ET
Branding Becomes Key as CBD is Expected to Overtake the Cannabis Market
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot reporting on the CBD market As it grows, branding becomes essential to companies hoping to stand out. According to Brightfield Group...
Feb 06, 2019 11:00 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Feb. 6, 2019 /CNW/ - Trading resumes in:
Feb 06, 2019 10:39 am ET
Khiron Life Sciences announces upsize of previously announced bought deal equity financing to $25 million
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 06, 2019 08:26 am ET
IIROC Trading Halt - KHRN
VANCOUVER, Feb. 6, 2019 /CNW/ - The following issues have been halted by IIROC:
Feb 06, 2019 06:31 am ET
Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 04, 2019 07:35 am ET
Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
NEW YORK, Feb. 4, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series,  and KCSA Strategic Communications, announced that the presentations from the January 30th Cannabis Virtual Conference are now available for on-demand viewing at VirtualInvestorConferences.com. ...